Stay updated with breaking news from மூலதனம் சீனா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
सोनम कपूर The BOF Show with Imran Amade के लॉन्च में इस खास अंदाज में हुईं शामिल sonam kapoor attends the launch of the bof show with imran amade bollywood Tadka bollywoodtadka.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bollywoodtadka.in Daily Mail and Mail on Sunday newspapers.
China Growth, Sequoia China back Vibe and 18 more deal updates from Greater China dealstreetasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dealstreetasia.com Daily Mail and Mail on Sunday newspapers.
By Kim Jae-heun The Korea Exchange (KRX), the country s top bourse operator, has decided to request Market Kurly s major shareholders to exercise joint ownership of the company s shares while limiting them from selling stocks following the online grocery service s initial public offering (IPO). The KRX wants to make it clear that the online retailer s initial public offering (IPO) here is possible as long as Kurly s CEO can maintain management control. Market Kurly CEO Kim Seul-ah, or Sophie Kim, only holds 7 percent of the company s shares and the bourse operator isn t ruling out the possibility that foreigner shareholders who have invested in Kurly with the hope of its successful IPO may sell off their holdings right after the listing. Local and overseas private equity funds (PEFs) are even said to be bracing for the possibility of a hostile takeover of Market Kurly. ....
В Китае запустили обратный отсчет 200 дней до открытия Зимней Олимпиады-2022 ukranews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ukranews.com Daily Mail and Mail on Sunday newspapers.
Seagen veteran-led ProfoundBio gets $55M to bring cancer drugs to the clinic Seagen veteran-led ProfoundBio gets $55M to bring cancer drugs to the clinic ProfoundBio is developing a type of targeted cancer therapy called antibody drug conjugates. As the biotech looks ahead to clinical trials, it has raised more than $55 million in Series A funding. Shares0
A biotech company developing targeted cancer therapies for solid tumors has raised more than $55 million in financing as it prepares to bring multiple drugs into human testing as early as next year. ProfoundBio unveiled the Series A round of funding on Monday. The investment was led by Lilly Asia Venture, along with LYFE Capital. ....